• In-depth analysis regarding drug availability, clinical data, clinical pipeline tracking, evidence-based clinical pathways, preferred products, and site of care

​​

• Disease class-specific strategy reports, drug alerts, pipeline trend reports, and new-drug reviews

 

• Assessments of potential new brand product prevalence and pricing impacts prior to launch

 

• Extensive trend analysis examining brand vs. generic clinical pathways, cost-effective therapies, and payer perspectives

 

• Pricing specific to competitive landscape including generic-launch projections, FDA action dates, sales, therapy costs, and price changes

 

• Trend reports highlighting disease classes and drug events important to payers, systems, and manufacturers throughout the country

​

• Clinical criteria, formulary coverage, step therapy, and limited distribution network tracking